心脏磁共振在非阻塞性冠状动脉心肌梗死中的临床影响:前瞻性多中心队列研究
这项国际多中心前瞻性队列研究纳入320例MINOCA患者,在CMR前后分别评估临床诊断、诊断确定性和拟定的临床管理。CMR与63%患者的诊断和/或管理改变相关,并显著提高诊断确定性;早期CMR、冠脉造影无动脉粥样硬化及CMR前诊断不确定性高者可预测上述改变。
要点
- MINOCA患者行CMR后63%出现诊断和/或管理改变,诊断确定性显著提高。
- 早期CMR(≤14天)、冠脉无粥样硬化及CMR前诊断不确定性高者从CMR获益更大。
- 对无阻塞性 culprit 病变却初始处方DAPT者,CMR用于停用DAPT的需检测人数为3。
核心结论
- MINOCA患者行CMR与临床诊断、诊断确定性和管理的显著改变相关。
- CMR对停用不必要的DAPT的影响可能对患者安全和费用有重要意义,值得进一步评估。
- 应考虑早期CMR以辅助MINOCA的诊断和管理。
研究设计与样本
- 国际多中心前瞻性队列研究,纳入320例MINOCA患者。
- 在CMR前后分别前瞻性确定临床诊断、诊断确定性和拟定的临床管理。
- 主要结局为临床诊断和/或管理改变的复合终点。
主要发现
- 320例患者中,CMR与63%(95% CI 57%至68%,p<0.001)的诊断和/或管理改变相关。
- CMR后诊断确定性显著提高:8/10(5-9) vs CMR前6/10(4-7),p<0.0001。
- 多变量分析中主要结局的相关预测因素为早期CMR(≤14天)、冠脉造影无粥样硬化及CMR前显著诊断不确定性(≤5/10)。
- 具备全部三个预测因素者CMR改变诊断和/或管理的比例为80%,无任何预测因素者为40%。
- 初始处方DAPT despite 无阻塞性 culprit 病变者,CMR用于停用DAPT的需检测人数为3。
临床怎么用
- 对MINOCA患者应考虑早期(≤14天)行CMR以辅助诊断和管理。
- 冠脉造影无粥样硬化且CMR前诊断不确定性高的MINOCA患者可能从CMR中获益更大。
- 对无阻塞性 culprit 病变却初始处方DAPT者,CMR可用于识别可停用DAPT的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiac magnetic resonance (CMR) may radiologically identify or confirm underlying pathophysiologies in myocardial infarction with non-obstructive coronary arteries (MINOCA), however, there are scant prospective data evaluating the impact on routine clinical care. METHODS: In a multicentre international cohort study of MINOCA, clinical diagnosis, diagnostic certainty and intended clinical management were prospectively determined before and again after CMR. The primary outcome was a composite of change in clinical diagnosis and/or management. Secondary outcomes were individual components of the primary outcome, change in diagnostic certainty and number-needed-to-test for deprescription of dual antiplatelet therapy (DAPT). Predictors of the primary outcome were evaluated by multivariable logistic regression analysis. RESULTS: In 320 patients, CMR was associated with change in diagnosis and/or management in 63% (95% CI 57% to 68%, p<0.001) and significantly increased diagnostic certainty (8/10 post-CMR (5-9) vs 6/10 pre-CMR (4-7), p<0.0001). Relevant predictors of the primary outcome on multivariable analysis were early CMR (≤14 days), absence of atheroma on coronary angiography and significant pre-CMR diagnostic uncertainty (≤5/10); CMR changed diagnosis and/or management in 80% of individuals with all three predictors versus 40% in those with none. In individuals where treating physicians initially chose to prescribe DAPT despite no obstructive culprit lesion, number-needed-to-test by CMR for DAPT deprescription was 3. CONCLUSIONS: CMR in MINOCA is associated with significant changes in clinical diagnosis, diagnostic certainty and management. The impact on deprescription of unnecessary DAPT could have important implications for patient safety and costs and warrants further evaluation. Early CMR should be considered to augment diagnosis and management in MINOCA. TRIAL REGISTRATION NUMBER: ISRCTN75233845.
引用
- Rajwani, Giudicatti, Telyuk, et al. Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study. Heart. 2025. PMID: 40514208. doi:10.1136/heartjnl-2024-325181
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。